Great Lakes Advisors LLC Sells 6,539 Shares of Addus HomeCare Corporation $ADUS

Key Points

• Great Lakes Advisors LLC reduced its holdings in Addus HomeCare by 23.9%, selling 6,539 shares and now owning about 0.11% of the company valued at approximately $2.06 million.
• Addus HomeCare reported $1.49 earnings per share for the last quarter, exceeding expectations, with revenue increasing by 21.8% year-over-year to $349.44 million.
• Analysts have mixed ratings on Addus HomeCare, with price targets ranging from $83 to $150, and an average target price of $138.89.

Great Lakes Advisors LLC lowered its stake in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 23.9% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,835 shares of the company's stock after selling 6,539 shares during the quarter. Great Lakes Advisors LLC owned 0.11% of Addus HomeCare worth $2,060,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the stock. Heritage Family Offices LLP grew its holdings in Addus HomeCare by 6.3% in the first quarter. Heritage Family Offices LLP now owns 2,417 shares of the company's stock worth $239,000 after purchasing an additional 143 shares during the period. Hohimer Wealth Management LLC grew its stake in shares of Addus HomeCare by 6.3% in the 1st quarter. Hohimer Wealth Management LLC now owns 2,561 shares of the company's stock valued at $253,000 after buying an additional 152 shares during the period. Polar Capital Holdings Plc grew its stake in shares of Addus HomeCare by 0.6% in the 4th quarter. Polar Capital Holdings Plc now owns 29,349 shares of the company's stock valued at $3,679,000 after buying an additional 185 shares during the period. Vista Finance LLC increased its position in Addus HomeCare by 7.0% in the 1st quarter. Vista Finance LLC now owns 2,994 shares of the company's stock valued at $296,000 after buying an additional 195 shares in the last quarter. Finally, Sheets Smith Wealth Management raised its stake in Addus HomeCare by 3.8% during the 1st quarter. Sheets Smith Wealth Management now owns 7,272 shares of the company's stock worth $719,000 after buying an additional 267 shares during the period. Institutional investors and hedge funds own 95.35% of the company's stock.

Insider Buying and Selling

In related news, CEO R Dirk Allison sold 25,000 shares of the business's stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $114.95, for a total transaction of $2,873,750.00. Following the transaction, the chief executive officer owned 166,461 shares in the company, valued at $19,134,691.95. The trade was a 13.06% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Brian Poff sold 7,739 shares of the business's stock in a transaction on Monday, August 25th. The shares were sold at an average price of $116.82, for a total transaction of $904,069.98. Following the transaction, the executive vice president directly owned 56,980 shares in the company, valued at approximately $6,656,403.60. The trade was a 11.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 34,310 shares of company stock valued at $3,958,375 over the last ninety days. 4.50% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on ADUS shares. JMP Securities reissued a "market outperform" rating and issued a $150.00 price objective on shares of Addus HomeCare in a research note on Wednesday, July 16th. Barclays boosted their target price on shares of Addus HomeCare from $83.00 to $109.00 and gave the stock an "underweight" rating in a research report on Tuesday, August 19th. Macquarie reissued an "outperform" rating and set a $133.00 price objective on shares of Addus HomeCare in a report on Tuesday, June 10th. Stephens restated an "overweight" rating and set a $140.00 price objective on shares of Addus HomeCare in a research note on Wednesday, September 3rd. Finally, Royal Bank Of Canada upped their target price on shares of Addus HomeCare from $133.00 to $134.00 and gave the stock an "outperform" rating in a research note on Friday, August 22nd. Two research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, Addus HomeCare presently has a consensus rating of "Buy" and a consensus price target of $138.89.

Addus HomeCare Price Performance

ADUS traded down $2.11 on Friday, reaching $110.27. The company had a trading volume of 86,255 shares, compared to its average volume of 118,442. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.74 and a current ratio of 1.74. The company has a market cap of $2.03 billion, a price-to-earnings ratio of 24.34, a P/E/G ratio of 1.71 and a beta of 0.85. The business has a 50 day simple moving average of $111.98 and a 200 day simple moving average of $107.21. Addus HomeCare Corporation has a 52-week low of $88.96 and a 52-week high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its earnings results on Monday, August 4th. The company reported $1.49 earnings per share for the quarter, topping analysts' consensus estimates of $1.45 by $0.04. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%.The company had revenue of $349.44 million during the quarter, compared to the consensus estimate of $345.71 million. During the same quarter in the previous year, the company posted $1.35 EPS. Addus HomeCare's quarterly revenue was up 21.8% compared to the same quarter last year. As a group, sell-side analysts anticipate that Addus HomeCare Corporation will post 4.59 EPS for the current year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.